» Articles » PMID: 25033378

Mechanisms of CFTR Functional Variants That Impair Regulated Bicarbonate Permeation and Increase Risk for Pancreatitis but Not for Cystic Fibrosis

Abstract

CFTR is a dynamically regulated anion channel. Intracellular WNK1-SPAK activation causes CFTR to change permeability and conductance characteristics from a chloride-preferring to bicarbonate-preferring channel through unknown mechanisms. Two severe CFTR mutations (CFTRsev) cause complete loss of CFTR function and result in cystic fibrosis (CF), a severe genetic disorder affecting sweat glands, nasal sinuses, lungs, pancreas, liver, intestines, and male reproductive system. We hypothesize that those CFTR mutations that disrupt the WNK1-SPAK activation mechanisms cause a selective, bicarbonate defect in channel function (CFTRBD) affecting organs that utilize CFTR for bicarbonate secretion (e.g. the pancreas, nasal sinus, vas deferens) but do not cause typical CF. To understand the structural and functional requirements of the CFTR bicarbonate-preferring channel, we (a) screened 984 well-phenotyped pancreatitis cases for candidate CFTRBD mutations from among 81 previously described CFTR variants; (b) conducted electrophysiology studies on clones of variants found in pancreatitis but not CF; (c) computationally constructed a new, complete structural model of CFTR for molecular dynamics simulation of wild-type and mutant variants; and (d) tested the newly defined CFTRBD variants for disease in non-pancreas organs utilizing CFTR for bicarbonate secretion. Nine variants (CFTR R74Q, R75Q, R117H, R170H, L967S, L997F, D1152H, S1235R, and D1270N) not associated with typical CF were associated with pancreatitis (OR 1.5, p = 0.002). Clones expressed in HEK 293T cells had normal chloride but not bicarbonate permeability and conductance with WNK1-SPAK activation. Molecular dynamics simulations suggest physical restriction of the CFTR channel and altered dynamic channel regulation. Comparing pancreatitis patients and controls, CFTRBD increased risk for rhinosinusitis (OR 2.3, p<0.005) and male infertility (OR 395, p<<0.0001). WNK1-SPAK pathway-activated increases in CFTR bicarbonate permeability are altered by CFTRBD variants through multiple mechanisms. CFTRBD variants are associated with clinically significant disorders of the pancreas, sinuses, and male reproductive system.

Citing Articles

Molecular mechanisms and pathological implications of unconventional protein secretion in human disease: from cellular stress to therapeutic targeting.

Liu Y, Zhang H, Li X, He T, Zhang W, Ji C Mol Biol Rep. 2025; 52(1):236.

PMID: 39955475 DOI: 10.1007/s11033-025-10316-6.


The enigmatic SLC26A6 multifunctional anion transporter: recent advances in structure-function relationship, pathophysiological significance and novel pharmacological inhibitors.

Seidler U Front Pharmacol. 2025; 15:1536864.

PMID: 39949394 PMC: 11821980. DOI: 10.3389/fphar.2024.1536864.


Germline multigene panel testing in acute and chronic pancreatitis.

Ramsey M, Heald B, Gokun Y, Baker J, Groce J, Han S PLoS One. 2024; 19(8):e0307076.

PMID: 39172977 PMC: 11341018. DOI: 10.1371/journal.pone.0307076.


Alterations in exocrine pancreatic function after acute pancreatitis.

Bejjani J, Ramsey M, Lee P, Evans Phillips A, Singh V, Yadav D Pancreatology. 2024; 24(4):505-510.

PMID: 38485543 PMC: 11215795. DOI: 10.1016/j.pan.2024.03.003.


Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epithelium.

Zajac M, Lepissier A, Dreano E, Chevalier B, Hatton A, Kelly-Aubert M Front Pharmacol. 2023; 14:1293578.

PMID: 38149052 PMC: 10750368. DOI: 10.3389/fphar.2023.1293578.


References
1.
Schechter M . Nongenetic influences on cystic fibrosis outcomes. Curr Opin Pulm Med. 2011; 17(6):448-54. DOI: 10.1097/MCP.0b013e32834ba899. View

2.
Highsmith Jr W, Friedman K, Burch L, Spock A, Silverman L, Boucher R . A CFTR mutation (D1152H) in a family with mild lung disease and normal sweat chlorides. Clin Genet. 2005; 68(1):88-90. DOI: 10.1111/j.1399-0004.2005.00459.x. View

3.
Dawson R, Locher K . Structure of a bacterial multidrug ABC transporter. Nature. 2006; 443(7108):180-5. DOI: 10.1038/nature05155. View

4.
Mussaffi H, Prais D, Mei-Zahav M, Blau H . Cystic fibrosis mutations with widely variable phenotype: the D1152H example. Pediatr Pulmonol. 2006; 41(3):250-4. DOI: 10.1002/ppul.20343. View

5.
Castellani C, Gomez Lira M, Frulloni L, Delmarco A, Marzari M, Bonizzato A . Analysis of the entire coding region of the cystic fibrosis transmembrane regulator gene in idiopathic pancreatitis. Hum Mutat. 2001; 18(2):166. DOI: 10.1002/humu.1172. View